Evidence map›Paper›PMID 31099450›Full record

ArticleCancer science2019

Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis.

Shimpei Matsui, Koji Okabayashi, Masashi Tsuruta, Kohei Shigeta, Ryo Seishima, Takashi Ishida, Takayuki Kondo, Yoshiyuki Suzuki, Hirotoshi Hasegawa, Masayuki Shimoda and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Spot-light on microbiota in obesity and cancer.International journal of obesity (2005) · 2021
    Review
  13. Review
  14. Review
  15. Review
  16. Organoid of ovarian cancer: genomic analysis and drug screening.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Shimpei MatsuiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Koji OkabayashiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Masashi TsurutaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Kohei ShigetaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Ryo SeishimaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Takashi IshidaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Takayuki KondoDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Yoshiyuki SuzukiDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Hirotoshi HasegawaDepartment of Surgery, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.
Masayuki ShimodaDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Shinya SugimotoDepartment of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.
Toshiro SatoDepartment of Gastroenterology, Keio University School of Medicine, Tokyo, Japan.
Yuko KitagawaDepartment of Surgery, Keio University School of Medicine, Tokyo, Japan.
Keio University · JPTokyo Dental College Ichikawa General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of colorectal cancer (CRC) has been on the rise, which is linked to the increasing prevalence of obesity, based on global epidemiological evidence. Although chronic inflammation is implicated in tumor development, the mechanisms underlying obesity-associated CRC remain unknown. Here, we sought to identify the inflammatory cytokines and their roles in obesity-related colorectal tumorigenesis using cytokine array analyses in a mouse model. Colorectal tumorigenesis was induced through i.p. injection of azoxymethane once a week for 6 weeks in 6-week-old female WT C57Black/6J mice and the obesity diabetes model mouse KK/TaJcl, KK-Ay/TaJcl. The formation of aberrant crypt foci and colorectal tumors were more frequent in obese mice compared with WT mice, and both serum interleukin (IL)-13 and IL-13 receptor (R) expression in the normal intestinal mucosal epithelium were significantly increased in the obese mice. Furthermore, addition of IL-13 to a human CRC cell line and a human colon organoid culture altered the phenotype of intestinal epithelial cells. Knockdown experiments further revealed that IL-13Rα1 dominantly induced mucosal proliferation. Collectively, These results suggest an association between anti-inflammatory cytokines and colorectal carcinogenesis, and provide new research directions for cancer prevention strategies. In particular, inflammation provoked by obesity, notably by increased expression of the cytokine IL-13, could play an important role in the carcinogenesis of obesity-related CRC.

Indexed as

Up-RegulationAberrant Crypt FociAnimalsAzoxymethaneCell ProliferationColorectal NeoplasmsDisease Models, AnimalFemaleGene Expression Regulation, NeoplasticHT29 CellsHumansInterleukin-13MiceMice, Inbred C57BLObesityPeritoneal AbsorptionAzoxymethaneIL13 protein, humanInterleukin-13Receptors, Interleukin-13carcinogenesiscolorectal cancercytokineIL-13obesity

Identifiers

PMID31099450
PMCPMC6609806
OpenAlexW2946318579

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.